Currently, the most important prognostic factors are nodal status, tumor size, hormone receptor (HR) status, and histological grade, although numerous other clinicopathological factors and novel molecular markers have been investigated to improve the prediction of clinical outcome [4,5]. Here, NR4A1 is linked to neoplasm.